Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An accumulation of endolymph in the inner ear (labyrinth) leading to buildup of pressure and distortion of intralabyrinthine structures, such as cochlea and semicircular canals. It is characterized by sensorineural hearing loss; tinnitus; and sometimes vertigo.
Biomarker and diagnostic research for endolymphatic hydrops has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
301 publications have been identified in PubMed for endolymphatic hydrops. Research spans Basic Science / Preclinical (22%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 65 | 22% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 12:22 AM UTC
Testing and diagnosis research |
61 |
20% |
Research summaries | 54 | 18% |
Disease patterns and progression | 45 | 15% |
Clinical study results | 40 | 13% |
Patient case studies | 22 | 7% |
New treatment approaches | 8 | 3% |
Other research | 6 | 2% |
Wang M (2026). [PMID: 42208960](https://pubmed.ncbi.nlm.nih.gov/42208960/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Diagnostic / Biomarker]
Wu Q (2026). [PMID: 41927093](https://pubmed.ncbi.nlm.nih.gov/41927093/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Basic Science / Preclinical]
Iațentiuc IM (2026). [PMID: 42193457](https://pubmed.ncbi.nlm.nih.gov/42193457/). *Biomedicines*. [Review / Meta-Analysis]
Naganawa S (2026). [PMID: 41016811](https://pubmed.ncbi.nlm.nih.gov/41016811/). *Magn Reson Med Sci*. [Diagnostic / Biomarker]
Dieterich M (2026). [PMID: 41262047](https://pubmed.ncbi.nlm.nih.gov/41262047/). *Current opinion in neurology*. [Review / Meta-Analysis]
Zhang X (2026). [PMID: 37649351](https://pubmed.ncbi.nlm.nih.gov/37649351/). *Ear Nose Throat J*. [Case Report / Case Series]
Lee JE (2026). [PMID: 42044083](https://pubmed.ncbi.nlm.nih.gov/42044083/). *Audiol Neurootol*. [Diagnostic / Biomarker]
Lorente-Piera J (2026). [PMID: 41731111](https://pubmed.ncbi.nlm.nih.gov/41731111/). *Eur Arch Otorhinolaryngol*. [Diagnostic / Biomarker]
Zavdy O (2026). [PMID: 42053150](https://pubmed.ncbi.nlm.nih.gov/42053150/). *Laryngoscope*. [Review / Meta-Analysis]
Gargula S (2026). [PMID: 40233420](https://pubmed.ncbi.nlm.nih.gov/40233420/). *Journal of vestibular research : equilibrium & orientation*. [Review / Meta-Analysis]